MRK
Merck & Co., Inc.
Set alert
- YTD
- +42.05%
- 1 year
- +73.30%
- Open
- 149.55
- Prev close
- 146.33
- Mkt cap
- 368.89B
- Vol
- 12.35M
- Avg vol
- 10.29M
- EPS
- 1.26
- P/E
- 118.67
- Div yield
- 2.32%
More statistics
- Low
- 147.43
- High
- 151.35
- Forward P/E
- 16.19
- Beta
- 0.00
- Short ratio
- 2.68
- Inst. own
- 82.88%
- Dividend
- 3.40
- Ex-div date
- Sep 14, 2026
- Earnings
- Feb 2, 2027
- 50-d avg
- 146.85
- 200-d avg
- 126.52
- 1y target
- 159.60
Discussion (165)
Sign in to join the discussion
Have you lost money to an online investment platform or financial scam? You’re not alone, and there may still be steps you can take. Our recovery support team helps clients gather evidence, document transactions, and navigate the recovery process with professionalism and transparency. We believe every case deserves careful attention. From your first consultation to ongoing updates, we’re committed to providing honest guidance and dedicated support. Contact William Jones today to discuss your situation and explore your available options with him on Telegram 📲 https://t.me/williams615
Omg Jim Cramer, POS, is praising Merck and Moderna melanoma mRNA combination and putting Merck into his portfolio today. What joke he is. Degree in drama and went to law school... When I add the two together I get a fraud, fake actor and a immoral liar.
$NWBO. $0.30 at open and above $0.48 at close. It will be an epic week. Dad’s revenge 05-13-98
Keytruda is finished move over Anktiva here comes ImmunityBio IBRX
MRNA is MRK next takeover target at $120 per share, it’s a matter of time.
$NWBO. About to departure. Still low price